Skip to main content

Dexcom Inc

DXCM
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0001093557

In the last 90 days, Dexcom Inc insiders filed 0 open-market purchases and 12 sales; 976 institutions reported holding it in 13F filings for Q2 2026, worth $26.0B in total; no superinvestor holds it.

13F holders, Q1 2022

Institutional positions in Dexcom Inc as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
862
−64 vs. Q4 2021
Shares held
94.8M
+2.40M (+2.6%) vs. Q4 2021
Total value
$48.3B
−$1.24B (−2.5%) vs. Q4 2021
New holders
76
350 more added
Sold out
140
306 more reduced

6 institutions that held it in Q4 2021 haven't filed for Q1 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q4 2021: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting DXCM on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ1 2022: 862 institutions
Q1 2021: 730 institutionsQ2 2021: 729 institutionsQ3 2021: 799 institutionsQ4 2021: 932 institutionsQ1 2022: 862 institutionsQ2 2022: 799 institutionsQ3 2022: 795 institutionsQ4 2022: 920 institutionsQ1 2023: 906 institutionsQ2 2023: 955 institutionsQ3 2023: 905 institutionsQ4 2023: 976 institutionsQ1 2024: 1,034 institutionsQ2 2024: 1,001 institutionsQ3 2024: 892 institutionsQ4 2024: 951 institutionsQ1 2025: 933 institutionsQ2 2025: 939 institutionsQ3 2025: 910 institutionsQ4 2025: 922 institutionsQ1 2026: 961 institutionsQ2 2026: 976 institutions
Value heldQ1 2022: $48.3B
Q1 2021: $33.1BQ2 2021: $40.5BQ3 2021: $51.3BQ4 2021: $49.6BQ1 2022: $48.3BQ2 2022: $27.6BQ3 2022: $29.6BQ4 2022: $41.8BQ1 2023: $42.9BQ2 2023: $47.4BQ3 2023: $34.4BQ4 2023: $46.9BQ1 2024: $51.1BQ2 2024: $42.4BQ3 2024: $24.1BQ4 2024: $27.9BQ1 2025: $24.8BQ2 2025: $31.9BQ3 2025: $24.5BQ4 2025: $24.9BQ1 2026: $23.4BQ2 2026: $26.0B
Institutions holding DXCM and their total value by quarter
QuarterHoldersValue
Q2 2026976$26.0B
Q1 2026961$23.4B
Q4 2025922$24.9B
Q3 2025910$24.5B
Q2 2025939$31.9B
Q1 2025933$24.8B
Q4 2024951$27.9B
Q3 2024892$24.1B
Q2 20241,001$42.4B
Q1 20241,034$51.1B
Q4 2023976$46.9B
Q3 2023905$34.4B
Q2 2023955$47.4B
Q1 2023906$42.9B
Q4 2022920$41.8B
Q3 2022795$29.6B
Q2 2022799$27.6B
Q1 2022862$48.3B
Q4 2021932$49.6B
Q3 2021799$51.3B
Q2 2021729$40.5B
Q1 2021730$33.1B

Institutions, Q1 2022

Shares, value and share of portfolio for each institution holding Dexcom Inc; share changes are against Q4 2021.

Institutions holding DXCM in Q1 2022
InstitutionSharesValue% of portfolioChange in sharesAction
Cassady Schiller Wealth Management, LLC0$00.00%−2−100.0%Sold out
McCarthy Grittinger Financial Group, LLC0$00.00%−1−100.0%Sold out
Andra AP-fonden––––Not filed
Reilly Financial Advisors, LLC––––Not filed
NEXT Financial Group, Inc––––Not filed
Carroll Financial Associates, Inc.––––Not filed
Bell Investment Advisors, Inc––––Not filed
Harbour Investments, Inc.––––Not filed